Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
Summary What is Known and Objective: Inhaled long-acting beta-agonists have been licensed for the treatment of chronic obstructive pulmonary disease (COPD) since the late 1990s, and they improve lung function and symptoms of dyspnoea. However, the evidence that long-acting beta-agonists alone can re...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 37; no. 2; pp. 204 - 212 |
|---|---|
| Autores principales: | , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Apr2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |